Zhi-Yuan Xu (Zhiyuan Xu)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Gas Chromatography

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao-Feng Wang, Can Hu, Shao-Wei Mo, Jing-Li Xu, Yan Liu, Han-Dong Xu, Li Yuan, Ling Huang, Jian-Fa Yu, Xiang-Dong Cheng, Zhi-Yuan Xu
GPR30 Activation Promotes the Progression of Gastric Cancer and Plays a Significant Role in the Anti-GC Effect of Huaier. Journal of oncology 2022 (2022)
Jielu Cao, Can Hu, Jingli Xu, Jing Han, Ruolan Zhang, Mengxuan Cao, Li Yuan, Zhi-Yuan Xu
Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Zhehan Bao, Yanqiang Zhang, Pengcheng Yu, Yi Wang, Xiang-Dong Cheng, Yuhang Xia, Li Yuan, Zhi-Yuan Xu, Xiang-Dong Cheng
High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)